The distinction that matters most is not which one caused it. It is whether the flatness is confined to food or extends across your life. Reduced interest in eating is the medication doing its job. Reduced interest in everything is a different finding, and it is worth reporting regardless of what caused it, because low mood matters on its own terms.<\/p>\n
Tell your provider either way. You do not need to work out the mechanism first, and trying to is the reason a lot of people say nothing for months.<\/p>\n
This deserves a clear account, because the coverage has been confusing.<\/p>\n
After postmarketing reports in 2023, the FDA investigated a possible link between GLP-1 medications and suicidal thoughts or behavior. A preliminary review reported in January 2024 did not find an association. The agency then conducted a more comprehensive analysis across the development programs for these drugs, and in January 2026 requested that the suicidal ideation and behavior warning be removed from the labeling of Saxenda, Wegovy, and Zepbound, on the basis that the review found no increased risk. European regulators reached a similar conclusion in 2024.<\/p>\n
Two things follow from that, and both matter.<\/p>\n
The evidence does not support these medications causing suicidal thoughts. And the FDA, in the same communication, continued to advise that anyone reporting suicidal ideation or behavior should be referred to a mental health professional for evaluation. Removing a warning about causation is not the same as saying mood changes do not need attention.<\/p>\n
Flatness confined to food.<\/strong> Less interest in meals, less anticipation, less satisfaction from eating. This is the expected effect and it is not a mood problem, though it can feel like a loss.<\/p>\n Flatness that extends further.<\/strong> Hobbies, people, work, and things you used to look forward to have all gone grey. That is a different picture and it needs raising.<\/p>\n The second one is easy to miss because it arrives gradually and because it is tempting to attribute it to the medication and wait.<\/p>\n Worth checking, because several are addressable:<\/p>\n Eating far less than your body needs.<\/strong> Low mood, irritability, and difficulty concentrating are part of the under-eating cluster, alongside persistent fatigue, feeling cold, hair shedding, dizziness on standing, and losing strength. If several of those are present, that is the most likely explanation and the most fixable.<\/p>\n Sleep.<\/strong> Often disrupted during a period of change, and it affects mood more than almost anything else.<\/p>\n The loss of a coping mechanism.<\/strong> If eating was how you managed stress, removing the capacity for it does not remove the stress. Something has to take that role.<\/p>\n Existing depression or anxiety.<\/strong> If you have a history, a period of change is a time to watch rather than assume.<\/p>\n Other medications<\/strong>, including ones started recently for something unrelated.<\/p>\n Life.<\/strong> Weight loss does not suspend everything else, and a difficult stretch is a difficult stretch.<\/p>\n Consider this scenario: a patient several months in mentions in passing that they have stopped seeing friends and have not touched a hobby they used to care about, then adds that it is probably just the medication. Their provider asks about the hobby rather than the medication, and it becomes clear this is not about appetite at all. Nobody had asked, and they had not thought it was the kind of thing to bring up at a weight management appointment.<\/p>\n It is exactly the kind of thing to bring up.<\/p>\n Point four matters more than people expect. If intake has dropped a long way, that is a treatable cause of low mood and it is the first thing worth ruling out.<\/p>\n If you are having thoughts of suicide or self-harm, contact a healthcare professional promptly, or in the US call or text 988 to reach the Suicide and Crisis Lifeline. This is worth doing before you work out whether the medication is involved.<\/p>\n Do not stop your medication abruptly<\/strong> on your own. If your provider decides to stop or change it, that should be planned. Our guide on taking a break and restarting<\/a> covers what an unplanned stop involves.<\/p>\n Do not eat less because you feel low.<\/strong> It compounds the problem directly.<\/p>\n Do not stop an antidepressant<\/strong> to see whether that is the cause.<\/p>\n Do not wait for a scheduled appointment<\/strong> if this has been going on for weeks.<\/p>\n Do not decide it is not worth mentioning<\/strong> at a weight appointment. It is.<\/p>\n Our guide on getting the most out of your GLP-1 treatment<\/a> covers the intake and sleep side, and our comparison of tirzepatide and semaglutide side effects<\/a> covers what is expected within this class.<\/p>\n Contact your provider if flatness extends beyond food, if it has lasted more than a couple of weeks, if you have a history of depression or anxiety, if you are eating very little, or if anyone who knows you has commented on a change in you.<\/p>\n Less interest in food is the medication working. Less interest in everything is a separate finding that deserves attention regardless of cause. The evidence does not support these medications causing suicidal thoughts, and the FDA removed that warning in 2026, while still advising that anyone reporting such thoughts be referred for evaluation. Report mood changes. You do not have to know the mechanism first.<\/p>\nOther things that produce this<\/h2>\n
What to tell your provider<\/h2>\n
\n
Get help promptly if<\/h2>\n
\n
What not to do<\/h2>\n
When to call<\/h2>\n
The short version<\/h2>\n